Several direct targets have been identified, including AKAP12 in hepatocellular carcinoma, PTEN in non-small-cell lung cancer and D52 in prostate cancer, have been reported to be targets of miR-103a-3p [38, 41, 44]. The gene discussed is PTEN; the disease is prostate cancer.